Lymphangioma of the Orbitopalpebral Area

Česká verzia

Authors: J. Krásný ¹; D. Baráková ¹; Z. Chodounský ²; J. Šach ³
Authors place of work: Oční klinika Fakultní nemocnice, Královské Vinohrady, Praha, přednosta: prof. MUDr. P. Kuchynka, CSc. ¹; Oddělení radioterapie Fakultní nemocnice Královské Vinohrady, Praha, přednosta: prim. MUDr. Z. Chodounský, CSc. (+) ²; Ústav patologie 3. LF a Fakultní nemocnice Královské Vinohrady, Praha, přednosta: prof. MUDr. V. Mandys, CSc. ³
Published in the journal: Čes. a slov. Oftal., 70, 2014, No. 4, p. 152-159
Category: Původní práce

Summary

Aim:
The authors refer about five patients with different types of lymphangioma, who were followed-up at the Department of Ophthalmology, Faculty Hospital Královské Vinohrady (King’s Vinegards), Charles University, Prague, Czech Republic, E.U., during the period 1995 – 2013; the follow-up period lasted from 5 to 17 years. The lymphangioma of the orbitopalpebral area is discussed according to the evaluation of the tumor development, histological verification, treatment, and its results.

Methods:
In four boys, the first signs of tumor were eyeball protrusion (exophthalmos) and bleeding into the conjunctiva or palpebral skin before the age of 5 years. In all four patients, the histological confirmation of the orbital lymphangioma was performed in the beginning of the disease. In three cases, it was the orbital type, and the fourth one was frontal type with bilateral orbital lymphangiomatosis. In one girl, there were present conjunctival changes only, appearing as one-sided hyperplastic changes. For these changes, she was followed-up since her 13 years of age under the false diagnosis of chronic conjunctivitis. The definite histological confirmation of only conjunctival lymphangioma was done from the diagnostic probatory biopsy not until ten years of symptoms and unsatisfactory treatment.

Results:
In the girl with superficial conjunctival lymphangioma and in the patient with lymphangiomatosis, the follow-up was recommended only. In two patients with extraconal type of orbital tumor, the total or sub-total resection was performed. In the years of the follow-up, the remission of the disease was observed. In the patient with mostly intraconal type of the tumor, causing decrease of the visual acuity according to the optic nerve neuropathy and macular cystoid edema, the focused actinotherapy by means of linear accelerator treatment with the dose of 30 Gy after previous evacuation of chocolate cysts under ultrasound control. The regression of the tumor and normalized visual functions lasted for 17 years.

Conclusion:
As method of treatment of extraconal lymphangiomas, it seems, it is its resection, and in the intraconal localization of the tumor it is the focused actinotherapy by means of linear accelerator.

Key words:
orbital lymphangioma, conjunctival lymphangioma, lymphangiomatosis, tumor resection, linear accelerator actinotherapy

Zdroje

1. Anton, M., Holoušová, M., et al.: Histiocytóza X a dětská očnice. Čs Oftal, 48; 1998: 176–180.

2. Baráková, D.: Echografie v oftalmologii. Professional Publishing., Praha, 152 s.

3. Berthout, A., Jacomet, P.V., et al.: Surgical treatment of diffuse adult orbital lymphangioma: two case studies. Fr J Ophthalmol, 31; 2008: 1006–1017.

4. Bond, J.B., Haik, B.G., et al.: Magnetic resonance imaging of orbital lymphangioma with and without gadolinium contrast enhancement. Ophthalmology, 99; 1992: 1316– 324.

5. Boulos, P.R., Harissi-Dagher, M., et al.: Intralesional injection of Tisseel fibrin glue for resection of lymphangiomas and other thin-walled orbital cysts. Ophthal. Plast Reconstr Surg, 21; 2005: 171–176.

6. Di Emidio, P., Chibbaro, S. et al.: Double skull lymphangioma. Case report and review of the literature. Orbit, 28; 2009: 293–296.

7. Dudea, S.M., Seceleanu, A., et al.: Doppler ultrasound assessment of intraocular and orbital tumors. Oftalmologia, 51; 2007: 87–92.

8. Eiferman, R.A., Gushard, R.H.: Chocolate cyst of the orbit. Ann Ophthalmol, 18, 1986: 156–157.

9. Gerinec, A., Galbavý, Š.: Efektivnost liečby kapilárného hemangiomu orbity lokálne podávanými kortikosteroidmi. Čs Oftal, 52; 1996: 356–361.

10. Gerinec, A., Elízová, I., Chynoranský, M.: Ochorienia orbity u dětí. Čs Oftal, 52; 1996: 279–285.

11. Gerinec, A., Chynoranský, M., Galbavý, Š.: Rhabdomyosarkóm orbity. Čs Oftal, 53; 1997: 11–17.

12. Gerinec, A.: Diagnostické problémy tumorov orbity u dětí. Folia Strabol Neuroophtalmol, 3; 2000, suppl.I.: 41–43.

13. Gerinec, A.: Detská oftalmológia, Osveta, Martin, 2005, s. 204.

14. Gondová, G., Sejnová, D., et al.: Liečba kapilárního hemagiomu orbity betablokátormi. Folia Strabol Neuroophthalmol, 10; 2009, suppl. I.: 82–83.

15. Gündüz, K., Demirel, S., et. al.: Correlation of surgical outcome with neuroimaging findings in periocular lymphangiomas. Ophtalmology, 113; 2006: 1231–1238.

16. Gündüz, K., Kurt, R.A.: Well-circumscribed orbital venous-lymphatic malformations with atypical features in children. Br J Ophthalmol, 93; 2009: 656–659.

17. Hayasaki, A., Nakamura, H., et al.: Successful treatment of intraorbital lymphangioma with tissue fibrin glue. Surg Neurol, 72; 2009: 722–724.

18. Hill, R.H. 3rd., Shields, W.E. 2nd., et al.: Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations. Ophtal Plast Reconstr Surg, 28; 2012: 119–125.

19. Chynoranský, M., Furdová, A., Olah, Z.: Exoftalmus podmíněný ochorením slzné žlázy. Čs Oftal, 50; 1994: 48–51.

20. Chynoranský, M., Furdová, A., Olah, Z.: Exenteracia očnice. Čs. Oftal., 50, 1994: 92–97.

21. Illif, V.J.: Orbital tumors in children. In Jakobiec, F.A.: Ocular and adnexal tumors. Aesculapius, Birmingham, 1978, p. 669–684.

22. Iliff, V.J., Green, V.R.: Orbital lymphangiomas. Ophthalmology, 86; 1979: 914–929.

23. Katz, S.E., Rootman, J., et al.: Combined venous lymphatic malformation of the orbit (so-called lymfangiomas). Association with noncontiguous intracranial vascular anomalies. Ophthalmology, 105; 1998: 176–184.

24. Kostolná, J., Gerinec, A., et al.: Odontogenná dermoidná cysta orbity (kazuistika). Čes a Slov Oftal, 67; 2001: 101–103.

25. Kozák, J., Pochop, P., Hubáček, M.: Chirurgické řešení následků onkologické léčby. Čes a Slov Oftal, 59; 2003: 113–118.

26. Krásný, J.: Nádory oka a jeho adnex v dětství. III. Orbita. Čes a Slov Oftal, 54; 1998: 50–55.

27. Krásný, J. Novák, V., Otradovec, J.: Orbitální protéza po exenteraci očnice se zachováním víček a spojivkového vaku. Čes a Slov Oftal, 62; 2006: 94–99.

28. Krásný, J., Šach, J., et al.: Orbitální tumory u dospělých – desetiletá studie. Čes a Slov Oftal, 64, 2008: 219–227.

29. Krist, P., Plesník, J.: Maligní lymfom orbity. Čes a Slov Oftal, 58; 2002: 247–253.

30. Kuchynka, P. a kol.: Oční lékařství, Grada, Praha, 2007, s. 627 a 650.

31. Lanuza, G.A., Banon, N.R., et. al.: Unsuccessful treatment with OK-432 pibanil for orbital lymphangioma. Arch. Soc. Esp Oftalmol, 87; 2012: 17–19.

32. Lemke, A.J., Kazi, I., et al.: Differential diagnosis of intraconal orbital masses using High-resolution MRI with surface coils in 78 patients. Rofo, 176; 2004: 1436–1446.

33. Matoušek, P., Lipina, R. et al.: Transnazální endoskopická chirurgie nádorů očnice. Čes a Slov Oftal, 68; 2012: 202–206.

34. Novák, Z., Pábl, L., et al.: Stereotaktická biopsie nádorů očnice. Čes a Slov Oftal., 53, 1997: 220–222.

35. Ogita, S., Tsuto, T., et al.: Treatment of lymphagiomas arising aroud cervico-facial region: Surgery, bleomycin and OK-432 therapy. Nihon Geka Gakkai Zasshi, 90; 1989: 1389–1391.

36. Ogita, S., Tsuto, T., et al.: OK-432 therapy in 64 patients with lymphagioma. J Pediatr Surg, 29, 1994: 784–785.

37. Ohtsuka, K., Hashimoto, M., Suzuki, Y.: A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthamol, 49; 2005: 49–55.

38. Okazaki, T., Iwatani, S., et al.: Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg, 42; 2007: 386–389.

39. Otradovec, J.: Choroby očnice, Avicenum, Praha, 1986, s. 111, 249–251.

40. Ozeki. M., Kanda, K., et al.: Propranolol as an Alternative Treatmant Option for Pediatric Lymphatic Malfomation. Tohoku J Exp Med, 229; 2013: 61–66:

41. Pliskvová, J. Pernica, P., Omelková, A.: Rhabdomysarkom orbity. Čs Oftal, 48; 1998: 295–300.

42. Pochop, P., Čumlivská, E., Kodet, R.: Využití CT pro lokalizování bioptické jehly při odběru tkáně z očnice. Čes. a Slov. Oftal., 58, 2002: 165–170.

43. Řehůřek, J., Autrata, R.: Ke klinické diagnostice rhabdomyosarkomu dětské očnice. Čs. Oftal, 53, 1997: 215–219.

44. Saraux, H., Laroche, L., et al.: Lymphangioma of the orbit. J Fr Ophtalmol, 8, 1985: 579–584.

45. Shields, J.A., Shields, C.L.: Orbital cysts of childhood-clasification, clinical features, and management. Surv Ophthalmol, 49; 2004: 281–299.

46. Shields, J.A., Shields, C.L, Scartozzi, R.: Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, Part 1., Ophthalmology, 111; 2004: 997–1008.

47. Schwarcz, R.M., Ben Simon, G.J., et al.: Sclerosing therapy first line treatment for low flow vascular lesions of the orbit. Am J Ophthamol, 141; 2006: 333–339.

48. Sires, B.S, Goins, C.R., et al.: Systematic corticoid use in orbital lymphangioma. Ophtal Plast Reconstr Surg, 17; 2001: 85–90.

49. Suzuki, Y., Obana, A., et al.: Managemant of orbital lymphangioma using intralesional injection of OK-432. Br J Ophtamol, 84; 200: 614–617.

50. Vachharajani, A., Paes, B.: Orbital lymphangioma with non-contiguous cerebral arteriovenous malformation, manifesting with trombocytopenia (Kasabach-Merritt syndrome) and intracranial hemorrhage. Acta Paediatr, 91, 2002: 98–99.

51. Yoon, J.S., Coi, J.B., et al.: Intralesional injection of OK-432 for vision-threatenig orbital lymphangioma. Graef Arch Clin Exp Ophthalmol, 245; 2007: 1031–1035.

52. Yue, H., Qian, J., et al: Treatment of orbital vascular malformations with intralesional injection of pingyagmycin. Br J Ophthalmol, 97; 2013: 739–745.